Back to all Publications

Pharmacodynamic Analysis of Eribulin Safety in Breast Cancer Patients Using Real-world Postmarketing Surveillance Data

June 22, 2018

Author(s): Takahisa Kawamura, Hidefumi Kasai, Valentina Fermanelli, Toshiaki Takahashi, Yukinori Sakata, Toshiyuki Matsuoka, Mika Ishii, Yusuke Tanigawara

Year: June 22, 2018

Recommended for you

eChalk Talk: Avoid getting “lost in translation” – Increase confidence in translational research using biosimulation

On-Demand Webinar

Simcyp Discovery Simulator

PBPK Modeling to Support Bioequivalence & Generic Product Approvals

FDA’s Digital Transformation: The Future of Technology and How to Prepare

On-Demand Webinar